The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Clinical Research to Improve the Oral Health of Older Adults (R01 Clinical Trial Not Allowed) |
93.121 |
PAR-19-239 |
| Revolutionizing Innovative, Visionary Environmental health Research (RIVER) (R35 Clinical Trial Not Allowed) |
93.113 |
RFA-ES-19-007 |
| Novel RNAs in Virology (including HIV) and Immune Regulation: Basic Science and Therapeutic Discovery (R21 Clinical Trial Not Allowed) |
93.855 |
PA-19-237 |
| Limited Competition for Adolescent Brain Cognitive Development (ABCD) Study - Linked Research Project Sites (Collaborative U01 Clinical Trial Not Allowed) |
93.242, 93.273, 93.279, 93.307, 93.313, 93.399, 93.853, 93.865 |
RFA-DA-20-002 |
| NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional) |
93.310 |
RFA-RM-19-005 |
| Limited Competition for Adolescent Brain Cognitive Development (ABCD) Study - Coordinating Center (U24 Clinical Trial Not Allowed) |
93.242, 93.273, 93.279, 93.307, 93.313, 93.399, 93.853, 93.865 |
RFA-DA-20-004 |
| Limited Competition for Adolescent Brain Cognitive Development (ABCD) Study - Data Analysis, Informatics and Resource Center (U24 Clinical Trial Not Allowed) |
93.242, 93.273, 93.279, 93.307, 93.313, 93.399, 93.853, 93.865 |
RFA-DA-20-003 |
| Limited Competition: Additional Sequencing for the Alzheimer's Disease Sequencing Project (U01 Clinical Trial Not Allowed) |
93.866 |
PAR-19-234 |
| Reducing the Duration of Untreated Psychosis in the United States (R34 Clinical Trial Required) |
93.242 |
PAR-19-235 |
| Reducing the Duration of Untreated Psychosis in the United States (R01 Clinical Trial Required) |
93.242 |
PAR-19-236 |
| Targeted Prevention for Tickborne Diseases (R01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-19-037 |
| Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Coordination, Analysis, and Scientific Outreach (UM1 Clinical Trial Not Allowed) |
93.279 |
RFA-DA-19-038 |
| Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: CNS Data Generation (UM1 Clinical Trial Not Allowed) |
93.279 |
RFA-DA-19-037 |
| Limited Competition: NIGMS Mature Synchrotron Resources for Structural Biology (P30 - Clinical Trial Not Allowed) |
93.859 |
PAR-19-232 |
| Advancing Biomarker Discovery and Novel Point-of-Care Diagnostics for Active TB Disease Detection in HIV-1 Infected and Exposed Children (R01 Clinical Trial Optional) |
93.855 |
RFA-AI-19-036 |
| NIH Directors Early Independence Awards (DP5 Clinical Trial Optional) |
93.310 |
RFA-RM-19-008 |
| NIH Directors Transformative Research Awards (R01 Clinical Trial Optional) |
93.310 |
RFA-RM-19-007 |
| NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed) |
93.867 |
PAR-19-231 |
| Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) |
93.396 |
RFA-CA-19-040 |
| Pragmatic clinical trial on efficacy of managing reduced iron stores on risk of clinically important events in older adults with heart failure and anemia (U01 Clinical Trial Required) |
93.866 |
PA-19-230 |
| Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) |
93.396 |
RFA-CA-19-041 |
| Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) |
93.396 |
RFA-CA-19-039 |
| ITCR: innovative algorithms (R21 Clinical Trial Optional) |
93.396 |
RFA-CA-19-038 |
| Limited Competition Centers of Excellence in Ethical, Legal and Social Implications (ELSI) Research (CEER) (RM1 Clinical Trial Optional) |
93.172 |
RFA-HG-19-012 |
| Development of Sample Sparing Assays for Monitoring Immune Responses (U24 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-19-017 |
| Optimizing the Management and Outcomes for Cancer Survivors Transitioning to Follow-up Care (R01 Clinical Trial Required) |
93.353, 93.393, 93.399 |
RFA-CA-19-035 |
| Limited Competition: Follow-up on Subjects, Integrative Data Analysis and Measurement of Viral Antibodies in The Environmental Determinants of Diabetes in The Young Study (TEDDY) (U01 Clinical Trial Not Allowed) |
93.847, 93.855 |
RFA-DK-18-512 |
| Informatics Methodology and Secondary Analyses for Immunology Data in ImmPort (UH2 Clinical Trial Not Allowed) |
93.855 |
PAR-19-229 |
| Institutional Translational Research Training Program (T32) |
93.853, 93.866 |
PAR-19-228 |
| Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional) |
93.847 |
RFA-DK-19-003 |
| Behavioral and Social Research to Address Health Disparities in the U.S. (Admin Supp Clinical Trial Optional) |
93.866 |
PA-19-226 |
| Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Independent Basic Experimental Studies with Humans Required) |
93.113 |
PAR-19-225 |
| Research Project Grants in Pediatric Rehabilitation (R01 Clinical Trial Optional) |
93.865 |
RFA-HD-20-005 |
| Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) |
93.279 |
PAR-19-223 |
| Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional) |
93.172, 93.847 |
PAR-19-222 |
| Atopic Dermatitis Research Network Leadership Center (UM1) Clinical Trial Required |
93.855 |
RFA-AI-19-014 |
| Atopic Dermatitis Research Network -Clinical Research Centers (U01 Clinical Trial Optional) |
93.855 |
RFA-AI-19-015 |
| U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (HIV/AIDS) (U01 Clinical Trial Optional) |
93.393, 93.394, 93.395, 93.396, 93.399, 93.855, 93.865 |
RFA-AI-19-023 |
| U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (R01 Clinical Trial Optional) |
93.855 |
RFA-AI-19-024 |
| U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (U01 Clinical Trial Optional) |
93.855 |
RFA-AI-19-025 |
Search Results 3561-3600 of 14606
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |
